Primrose Bio will supply its industry-leading carrier protein, PeliCRM197®, for vaccine developmentIntravacc has knowhow in vaccine conjugation ...

The 2025-2027 approval helps French innovators access Intravacc’s vaccine development, analytical development and cGMP manufacturing services ...

The 2025-2027 approval helps French innovators access Intravacc's vaccine development, analytical development and cGMP manufacturing services French Ministry approval recognizes Intravacc as a private ...

MANILA, Philippines — Vaccines are a must for babies and children. The same can be said for adults whose immune systems are ...

Collectively, the deals reposition vaccines as long-horizon disease-modifying infrastructure, leveraging epidemiologic and mechanistic links between infections (eg, VZV, EBV) and neurodegeneration, ...

While vaccinations are often linked to babies and children, adults need them just as much, especially seniors whose immune ...

A1, a Potential Best-in-Class Vaccine Candidate Designed to Provide Broad Protection Against Disease Caused by Group A Streptococcus Two-Stage, Dose-Escalation Study Designed with Primary Objective to ...

Brodie abscesses commonly form in the epiphyseal region and, when they involve the growth plate, late complications such as ...

Eli Lilly has agreed to acquire three privately-held developers of vaccines for infectious diseases for a combined up-to-$3.83 billion cash, in deals intended to expand the acquisitive pharma giant’s ...

Pneumonia Risk Factors: Doctors recommend getting the pneumonia vaccine, also known as the pneumococcal vaccine. This vaccine ...

Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated ...

Pfizer (PFE) on Wednesday announced that it has begun a Phase 3 trial for its 25-valent pneumococcal vaccine, PF-07872412 (25vPnC), for infants after the shot outperformed its pneumococcal 20-valent ...